Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
about
Gene expression profiling in undifferentiated thyroid carcinoma induced by high-dose radiation.Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer.Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer.Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy.The impact of pharmacokinetic gene profiles across human cancers.Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
P2860
Q37025523-849C11A2-ECE5-4AB3-BC58-2618B14B9742Q37102453-1DAAC7F7-3329-4662-96C2-D027058EED0EQ38614394-32110E45-179C-4EFC-A584-5F8CF67F1B52Q39328851-746991EE-8522-4F78-A31E-76C169189CA2Q47298592-11D8569A-8595-4908-A110-D859946DAF2CQ47631967-46F9A53C-EA18-4656-B499-186ECE239B53Q55294975-C3D3FCA3-6CC9-43C0-82FC-96E82E95832BQ59129787-6517EF81-743D-4B1F-AFD2-CFFDCBD30D66
P2860
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
@ast
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
@en
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
@nl
type
label
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
@ast
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
@en
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
@nl
prefLabel
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
@ast
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
@en
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
@nl
P2860
P50
P3181
P356
P1433
P1476
Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer
@en
P2093
Joe S Mymryk
John W Barrett
P2860
P304
P3181
P356
10.1155/2014/936285
P407
P577
2014-01-01T00:00:00Z